Needham & Company downgraded Hologic (NASDAQ: HOLX) from Buy to Hold saying the turnaround is already reflected in the stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE